U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07787247) titled 'Feasibility of Remote Monitoring of Patients With Myasthenia Gravis' on Aug. 17.
Brief Summary: Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the mon...